Evidence map›Paper›PMID 39929810›Full record

ArticleNature communications2025

ER-mitochondria contacts mediate lipid radical transfer via RMDN3/PTPIP51 phosphorylation to reduce mitochondrial oxidative stress.

Isshin Shiiba, Naoki Ito, Hijiri Oshio, Yuto Ishikawa, Takahiro Nagao, Hiroki Shimura, Kyu-Wan Oh, Eiki Takasaki, Fuya Yamaguchi, Ryoan Konagaya and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Isshin ShiibaLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan. isshin.shiiba@gakushuin.ac.jp.
Naoki ItoLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.ORCID http://orcid.org/0009-0003-8182-7471
Hijiri OshioLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Yuto IshikawaLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Takahiro NagaoDepartment of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan.
Hiroki ShimuraLaboratory of Regenerative Medicine, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Kyu-Wan OhResearch Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Korea.
Eiki TakasakiLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Fuya YamaguchiLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Ryoan KonagayaLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Hisae KadowakiLaboratory of Biochemistry and Molecular Biology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.ORCID http://orcid.org/0009-0000-4795-2656
Hideki NishitohLaboratory of Biochemistry and Molecular Biology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.ORCID http://orcid.org/0000-0002-8652-4109
Takehito TanzawaInstitute for Protein Research, Osaka University, Suita, Osaka, 565-0871, Japan.ORCID http://orcid.org/0000-0002-4853-5288
Shun NagashimaLaboratory of Regenerative Medicine, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.ORCID http://orcid.org/0000-0001-8042-0897
Ayumu SugiuraDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Juntendo University, Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
Yuuta FujikawaSchool of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.ORCID http://orcid.org/0000-0002-5872-8462
Keitaro UmezawaResearch Team for Mechanism of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.ORCID http://orcid.org/0000-0002-2380-4453
Yasushi TamuraFaculty of Science, Yamagata University, 1-4-12 Kojirakawa-machi, Yamagata, Yamagata, 990-8560, Japan.ORCID http://orcid.org/0000-0002-8462-0607
Byung Il LeeResearch Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Korea.ORCID http://orcid.org/0000-0003-1270-8439
Yusuke HirabayashiDepartment of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan.ORCID http://orcid.org/0000-0003-3950-6781
Yasushi OkazakiDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Juntendo University, Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3241-5502
Tomohiro SawaDepartment of Microbiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Ryoko InatomeLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan.
Shigeru YanagiLaboratory of Molecular Biochemistry, Department of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, 171-8588, Japan. shigeru.yanagi@gakushuin.ac.jp.ORCID http://orcid.org/0000-0002-1392-8663

Funding

Japan Agency for Medical Research and Development (AMED) 23gm1610011h0001Japan Agency for Medical Research and Development (AMED) JP17gm5010002, JP18gm5010002, JP19gm5010002, JP20gm5010002Japan Agency for Medical Research and Development (AMED) JP19dm0207082MEXT | Japan Society for the Promotion of Science (JSPS) 21H0207, 21H05267, 23K17979MEXT | Japan Society for the Promotion of Science (JSPS) 21K06844MEXT | Japan Society for the Promotion of Science (JSPS) 22H05532MEXT | Japan Society for the Promotion of Science (JSPS) 22K15399, 22H05574, 24H01327MEXT | Japan Society for the Promotion of Science (JSPS) 23H02691,20H04911,20H03454MEXT | Japan Society for the Promotion of Science (JSPS) 23K14185, 22K20637
6 · The paper itself

Abstract

The proximal domains of mitochondria and the endoplasmic reticulum (ER) are linked by tethering factors on each membrane, allowing the efficient transport of substances, including lipids and calcium, between them. However, little is known about the regulation and function of mitochondria-ER contacts (MERCs) dynamics under mitochondrial damage. In this study, we apply NanoBiT technology to develop the MERBiT system, which enables the measurement of reversible MERCs formation in living cells. Analysis using this system suggests that induction of mitochondrial ROS increases MERCs formation via RMDN3 (also known as PTPIP51)-VAPB tethering driven by RMDN3 phosphorylation. Disruption of this tethering caused lipid radical accumulation in mitochondria, leading to cell death. The lipid radical transfer activity of the TPR domain in RMDN3, as revealed by an in vitro liposome assay, suggests that RMDN3 transfers lipid radicals from mitochondria to the ER. Our findings suggest a potential role for MERCs in cell survival strategy by facilitating the removal of mitochondrial lipid radicals under mitochondrial damage.

Indexed as

Endoplasmic ReticulumMitochondriaMitochondrial ProteinsOxidative StressAnimalsFree RadicalsHeLa CellsHumansPhosphorylationReactive Oxygen SpeciesFree RadicalsMitochondrial ProteinsReactive Oxygen Species

Identifiers

PMID39929810
PMCPMC11811300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.